BeStock  
Stocks › Biotechnology › GENB

Generate Biomedicines GENB

US equityMarket cap rank #2863Biotechnology
$13.91 +$0.22 (+1.61%)
Pre-market · Oct 6, 4:10 am ET · After hours $13.94 +0.20%
Open$13.71
Prev close$13.69
Day range$13.45 – $14.06
Volume1.12M
Market cap$1.79B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts3
Average target$26.00+86.9% vs. price
  • Buy 100%
Low $22.00Now $13.91Avg $26.00High $30.00

Recent rating changes

The last 20 actions on file set price targets from $13.75 to $30.00, averaging $25.14.

DateFirmRatingTarget
5 Oct 2026 H.C. Wainwright BUY $30.00
2 Oct 2026 Piper Sandler BUY $26.00
9 Sep 2026 H.C. Wainwright BUY $30.00
8 Sep 2026 H.C. Wainwright BUY $30.00
28 Aug 2026 H.C. Wainwright BUY $30.00
17 Aug 2026 Morgan Stanley BUY $22.00
7 Aug 2026 Piper Sandler BUY $24.00
7 Aug 2026 H.C. Wainwright BUY $25.00
24 Jun 2026 Guggenheim BUY $30.00
15 Jun 2026 Guggenheim BUY $30.00
14 May 2026 Morgan Stanley BUY $22.00
8 May 2026 Piper Sandler BUY $24.00
8 May 2026 H.C. Wainwright BUY $25.00
13 Apr 2026 H.C. Wainwright BUY $16.00
9 Apr 2026 Goldman Sachs BUY $26.00
24 Mar 2026 Cantor Fitzgerald BUY –
24 Mar 2026 Piper Sandler BUY $24.00
24 Mar 2026 Morgan Stanley BUY $20.00
24 Mar 2026 Goldman Sachs BUY $13.75
24 Mar 2026 Guggenheim BUY $30.00

Discussion

No comments yet — be the first to weigh in on GENB.

Leave a comment

Scroll to Top